UFIS-SWE-IG
0.1.0 - ci-build
UFIS-SWE-IG
0.1.0 - ci-build
UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions
{
"resourceType" : "Bundle",
"id" : "Yaz-0023mg-tablet-SE-AJ-MPD-BBDL",
"type" : "collection",
"entry" : [
{
"fullUrl" : "https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/MedicinalProductDefinition/Yaz-0023mg-tablet-SE-AJ-MPD",
"resource" : {
"resourceType" : "MedicinalProductDefinition",
"id" : "Yaz-0023mg-tablet-SE-AJ-MPD",
"meta" : {
"profile" : [
🔗 "http://unicom-project.eu/fhir/StructureDefinition/PPLMedicinalProductDefinition"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"MedicinalProductDefinition_Yaz-0023mg-tablet-SE-AJ-MPD\"> </a><p class=\"res-header-id\"><b>Generated Narrative: MedicinalProductDefinition Yaz-0023mg-tablet-SE-AJ-MPD</b></p><a name=\"Yaz-0023mg-tablet-SE-AJ-MPD\"> </a><a name=\"hcYaz-0023mg-tablet-SE-AJ-MPD\"> </a><a name=\"hcYaz-0023mg-tablet-SE-AJ-MPD-en-US\"> </a><p><b>identifier</b>: <code>http://ema.europa.eu/fhir/mpId</code>/SE-100004813-00026267, <code>http://ema.europa.eu/fhir/eurdId</code>/10217</p><p><b>domain</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000000004 100000000012}\">Human use</span></p><p><b>status</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/200000005003 200000005004}\">Current</span></p><p><b>combinedPharmaceuticalDoseForm</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/200000000004 100000073665}\">Film-coated tablet</span></p><p><b>indication</b>: </p><div><p>Antikonception Vid beslut att förskriva Yasminelle 28 ska den enskilda kvinnans riskfaktorer beaktas, framför allt de för venös tromboembolism (VTE), och risken för VTE med Yasminelle 28 jämfört med andra kombinerade hormonella preventivmedel (se avsnitt 4.3 och 4.4).</p>\n</div><p><b>legalStatusOfSupply</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000072051 100000072084}\">Medicinal product subject to medical prescription</span></p><p><b>classification</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000093533 100000095785}\">drospirenone and ethinylestradiol</span></p><blockquote><p><b>name</b></p><p><b>productName</b>: Yaz 0,02 mg/3 mg Filmdragerad tablett</p><blockquote><p><b>part</b></p><p><b>part</b>: Yaz</p><p><b>type</b>: <span title=\"Codes:{http://spor.ema.europa.eu/v1/lists/220000000000 220000000002}\">Invented Name Part</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: 0,02 mg/3 mg</p><p><b>type</b>: <span title=\"Codes:{http://spor.ema.europa.eu/v1/lists/220000000000 220000000004}\">Strength part</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: Filmdragerad tablett</p><p><b>type</b>: <span title=\"Codes:{http://spor.ema.europa.eu/v1/lists/220000000000 220000000005}\">Pharmaceutical dose form part</span></p></blockquote><h3>Usages</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Country</b></td><td><b>Language</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000000002 100000000535}\">Kingdom of Sweden</span></td><td><span title=\"Codes:{urn:ietf:bcp:47 sv}\">Swedish</span></td></tr></table></blockquote></div>"
},
"identifier" : [
{
"system" : "http://ema.europa.eu/fhir/mpId",
"value" : "SE-100004813-00026267"
},
{
"system" : "http://ema.europa.eu/fhir/eurdId",
"value" : "10217"
}
],
"domain" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000000004",
"code" : "100000000012",
"display" : "Human use"
}
]
},
"status" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/200000005003",
"code" : "200000005004",
"display" : "Current"
}
]
},
"combinedPharmaceuticalDoseForm" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/200000000004",
"code" : "100000073665",
"display" : "Film-coated tablet"
}
]
},
"indication" : "Antikonception Vid beslut att förskriva Yasminelle 28 ska den enskilda kvinnans riskfaktorer beaktas, framför allt de för venös tromboembolism (VTE), och risken för VTE med Yasminelle 28 jämfört med andra kombinerade hormonella preventivmedel (se avsnitt 4.3 och 4.4).",
"legalStatusOfSupply" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000072051",
"code" : "100000072084",
"display" : "Medicinal product subject to medical prescription"
}
]
},
"classification" : [
{
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000093533",
"code" : "100000095785",
"display" : "drospirenone and ethinylestradiol"
}
]
}
],
"name" : [
{
"productName" : "Yaz 0,02 mg/3 mg Filmdragerad tablett",
"part" : [
{
"part" : "Yaz",
"type" : {
"coding" : [
{
"system" : "http://spor.ema.europa.eu/v1/lists/220000000000",
"code" : "220000000002",
"display" : "Invented Name Part"
}
]
}
},
{
"part" : "0,02 mg/3 mg",
"type" : {
"coding" : [
{
"system" : "http://spor.ema.europa.eu/v1/lists/220000000000",
"code" : "220000000004",
"display" : "Strength part"
}
]
}
},
{
"part" : "Filmdragerad tablett",
"type" : {
"coding" : [
{
"system" : "http://spor.ema.europa.eu/v1/lists/220000000000",
"code" : "220000000005",
"display" : "Pharmaceutical dose form part"
}
]
}
}
],
"usage" : [
{
"country" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000000002",
"code" : "100000000535",
"display" : "Kingdom of Sweden"
}
]
},
"language" : {
"coding" : [
{
"system" : "urn:ietf:bcp:47",
"code" : "sv",
"display" : "Swedish"
}
]
}
}
]
}
]
}
},
{
"fullUrl" : "https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/RegulatedAuthorization/Yaz-0023mg-tablet-SE-AJ-RA",
"resource" : {
"resourceType" : "RegulatedAuthorization",
"id" : "Yaz-0023mg-tablet-SE-AJ-RA",
"meta" : {
"profile" : [
🔗 "http://unicom-project.eu/fhir/StructureDefinition/PPLRegulatedAuthorization"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"RegulatedAuthorization_Yaz-0023mg-tablet-SE-AJ-RA\"> </a><p class=\"res-header-id\"><b>Generated Narrative: RegulatedAuthorization Yaz-0023mg-tablet-SE-AJ-RA</b></p><a name=\"Yaz-0023mg-tablet-SE-AJ-RA\"> </a><a name=\"hcYaz-0023mg-tablet-SE-AJ-RA\"> </a><a name=\"hcYaz-0023mg-tablet-SE-AJ-RA-en-US\"> </a><p><b>identifier</b>: <code>http://ema.europa.eu/fhir/marketingAuthorizationNumber</code>/26267</p><p><b>subject</b>: <a href=\"MedicinalProductDefinition-Yaz-0023mg-tablet-SE-AJ-MPD.html\">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100004813-00026267,http://ema.europa.eu/fhir/eurdId#10217; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Film-coated tablet; indication = Antikonception Vid beslut att förskriva Yasminelle 28 ska den enskilda kvinnans riskfaktorer beaktas, framför allt de för venös tromboembolism (VTE), och risken för VTE med Yasminelle 28 jämfört med andra kombinerade hormonella preventivmedel (se avsnitt 4.3 och 4.4).; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = drospirenone and ethinylestradiol</a></p><p><b>type</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/220000000060 220000000061}\">Marketing Authorisation</span></p><p><b>region</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000000002 100000000535}\">Kingdom of Sweden</span></p><p><b>status</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000072049 100000072099}\">Valid</span></p><p><b>statusDate</b>: 2008-07-03</p><p><b>holder</b>: <a href=\"Organization-LOC-100016468.html\">Organization Bayer AB</a></p><h3>Cases</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Type</b></td><td><b>Date[x]</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://ema.europa.eu/fhir/authorisationDateType dateOfFirstAuthorisation}\">First Authorisation</span></td><td>2008-07-03</td></tr></table></div>"
},
"identifier" : [
{
"system" : "http://ema.europa.eu/fhir/marketingAuthorizationNumber",
"value" : "26267"
}
],
"subject" : [
{
🔗 "reference" : "MedicinalProductDefinition/Yaz-0023mg-tablet-SE-AJ-MPD"
}
],
"type" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/220000000060",
"code" : "220000000061",
"display" : "Marketing Authorisation"
}
]
},
"region" : [
{
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000000002",
"code" : "100000000535",
"display" : "Kingdom of Sweden"
}
]
}
],
"status" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000072049",
"code" : "100000072099",
"display" : "Valid"
}
]
},
"statusDate" : "2008-07-03",
"holder" : {
🔗 "reference" : "Organization/LOC-100016468"
},
"case" : {
"type" : {
"coding" : [
{
"system" : "https://ema.europa.eu/fhir/authorisationDateType",
"code" : "dateOfFirstAuthorisation",
"display" : "First Authorisation"
}
]
},
"dateDateTime" : "2008-07-03"
}
}
},
{
"fullUrl" : "https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/PackagedProductDefinition/Yaz-0023mg-tablet-SE-AJ-PPD",
"resource" : {
"resourceType" : "PackagedProductDefinition",
"id" : "Yaz-0023mg-tablet-SE-AJ-PPD",
"meta" : {
"profile" : [
🔗 "http://unicom-project.eu/fhir/StructureDefinition/PPLPackagedProductDefinition"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"PackagedProductDefinition_Yaz-0023mg-tablet-SE-AJ-PPD\"> </a><p class=\"res-header-id\"><b>Generated Narrative: PackagedProductDefinition Yaz-0023mg-tablet-SE-AJ-PPD</b></p><a name=\"Yaz-0023mg-tablet-SE-AJ-PPD\"> </a><a name=\"hcYaz-0023mg-tablet-SE-AJ-PPD\"> </a><a name=\"hcYaz-0023mg-tablet-SE-AJ-PPD-en-US\"> </a><p><b>identifier</b>: <code>http://ema.europa.eu/example/pcid</code>/?ngen-9?</p><p><b>packageFor</b>: <a href=\"MedicinalProductDefinition-Yaz-0023mg-tablet-SE-AJ-MPD.html\">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100004813-00026267,http://ema.europa.eu/fhir/eurdId#10217; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Film-coated tablet; indication = Antikonception Vid beslut att förskriva Yasminelle 28 ska den enskilda kvinnans riskfaktorer beaktas, framför allt de för venös tromboembolism (VTE), och risken för VTE med Yasminelle 28 jämfört med andra kombinerade hormonella preventivmedel (se avsnitt 4.3 och 4.4).; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = drospirenone and ethinylestradiol</a></p><p><b>containedItemQuantity</b>: 84 tablet<span style=\"background: LightGoldenRodYellow\"> (Details: 200000000014 code200000002152 = '200000002152')</span></p><p><b>description</b>: </p><div><p>Blister, 3 x 28 tabletter</p>\n</div><h3>MarketingStatuses</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Country</b></td><td><b>Status</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000000002 100000000535}\">Kingdom of Sweden</span></td><td><span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000072052 100000072083}\">Marketed</span></td></tr></table><blockquote><p><b>packaging</b></p><p><b>type</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000073346 100000073498}\">Box</span></p><p><b>quantity</b>: 1</p><p><b>material</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/200000003199 200000003208}\">Plastic</span></p><blockquote><p><b>packaging</b></p></blockquote></blockquote></div>"
},
"identifier" : [
{
"system" : "http://ema.europa.eu/example/pcid"
}
],
"packageFor" : [
{
🔗 "reference" : "MedicinalProductDefinition/Yaz-0023mg-tablet-SE-AJ-MPD"
}
],
"containedItemQuantity" : [
{
"value" : 84,
"unit" : "tablet",
"system" : "http://spor.ema.europa.eu/v1/lists/200000000014",
"code" : "200000002152"
}
],
"description" : "Blister, 3 x 28 tabletter",
"marketingStatus" : [
{
"country" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000000002",
"code" : "100000000535",
"display" : "Kingdom of Sweden"
}
]
},
"status" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000072052",
"code" : "100000072083",
"display" : "Marketed"
}
]
}
}
],
"packaging" : {
"type" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000073346",
"code" : "100000073498",
"display" : "Box"
}
]
},
"quantity" : 1,
"material" : [
{
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/200000003199",
"code" : "200000003208",
"display" : "Plastic"
}
]
}
],
"packaging" : [
{
"type" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000073346",
"code" : "100000073498",
"display" : "Box"
}
]
},
"quantity" : 3,
"material" : [
{
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/200000003199",
"code" : "200000003529",
"display" : "Cardboard"
}
]
}
],
"packaging" : [
{
"type" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000073346",
"code" : "100000073496",
"display" : "Blister"
}
]
},
"quantity" : 1,
"material" : [
{
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/200000003199",
"code" : "200000003200",
"display" : "Aluminium"
}
]
},
{
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/200000003199",
"code" : "200000003222",
"display" : "PolyVinyl Chloride"
}
]
}
],
"containedItem" : [
{
"item" : {
"reference" : {
🔗 "reference" : "ManufacturedItemDefinition/Yaz-0023mg-tablet-SE-AJ-MID01"
}
},
"amount" : {
"value" : 24,
"unit" : "tablet",
"system" : "http://spor.ema.europa.eu/v1/lists/200000000014",
"code" : "200000002152"
}
},
{
"item" : {
"reference" : {
"reference" : "ManufacturedItemDefinition/Yaz-0023mg-tablet-SE-AJ-MID02"
}
},
"amount" : {
"value" : 4,
"unit" : "tablet",
"system" : "http://spor.ema.europa.eu/v1/lists/100000110633~200000000014",
"code" : "200000002152"
}
}
]
}
]
}
]
}
}
},
{
"fullUrl" : "https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/ManufacturedItemDefinition/Yaz-0023mg-tablet-SE-AJ-MID01",
"resource" : {
"resourceType" : "ManufacturedItemDefinition",
"id" : "Yaz-0023mg-tablet-SE-AJ-MID01",
"meta" : {
"profile" : [
🔗 "http://unicom-project.eu/fhir/StructureDefinition/PPLManufacturedItemDefinition"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"ManufacturedItemDefinition_Yaz-0023mg-tablet-SE-AJ-MID01\"> </a><p class=\"res-header-id\"><b>Generated Narrative: ManufacturedItemDefinition Yaz-0023mg-tablet-SE-AJ-MID01</b></p><a name=\"Yaz-0023mg-tablet-SE-AJ-MID01\"> </a><a name=\"hcYaz-0023mg-tablet-SE-AJ-MID01\"> </a><a name=\"hcYaz-0023mg-tablet-SE-AJ-MID01-en-US\"> </a><p><b>status</b>: Active</p><p><b>manufacturedDoseForm</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/200000000004 100000073665}\">Film-coated tablet</span></p><p><b>unitOfPresentation</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/200000000014 200000002152}\">tablet</span></p></div>"
},
"status" : "active",
"manufacturedDoseForm" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/200000000004",
"code" : "100000073665",
"display" : "Film-coated tablet"
}
]
},
"unitOfPresentation" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/200000000014",
"code" : "200000002152",
"display" : "tablet"
}
]
}
}
},
{
"fullUrl" : "https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/Ingredient/Yaz-0023mg-tablet-SE-AJ-ING01",
"resource" : {
"resourceType" : "Ingredient",
"id" : "Yaz-0023mg-tablet-SE-AJ-ING01",
"meta" : {
"profile" : [
🔗 "http://unicom-project.eu/fhir/StructureDefinition/PPLIngredient"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Ingredient_Yaz-0023mg-tablet-SE-AJ-ING01\"> </a><p class=\"res-header-id\"><b>Generated Narrative: Ingredient Yaz-0023mg-tablet-SE-AJ-ING01</b></p><a name=\"Yaz-0023mg-tablet-SE-AJ-ING01\"> </a><a name=\"hcYaz-0023mg-tablet-SE-AJ-ING01\"> </a><a name=\"hcYaz-0023mg-tablet-SE-AJ-ING01-en-US\"> </a><p><b>status</b>: Active</p><p><b>for</b>: </p><ul><li><a href=\"MedicinalProductDefinition-Yaz-0023mg-tablet-SE-AJ-MPD.html\">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100004813-00026267,http://ema.europa.eu/fhir/eurdId#10217; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Film-coated tablet; indication = Antikonception Vid beslut att förskriva Yasminelle 28 ska den enskilda kvinnans riskfaktorer beaktas, framför allt de för venös tromboembolism (VTE), och risken för VTE med Yasminelle 28 jämfört med andra kombinerade hormonella preventivmedel (se avsnitt 4.3 och 4.4).; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = drospirenone and ethinylestradiol</a></li><li><a href=\"ManufacturedItemDefinition-Yaz-0023mg-tablet-SE-AJ-MID01.html\">ManufacturedItemDefinition: status = active; manufacturedDoseForm = Film-coated tablet; unitOfPresentation = tablet</a></li><li><a href=\"AdministrableProductDefinition-Yaz-0023mg-tablet-SE-AJ-APD01.html\">AdministrableProductDefinition: status = active; administrableDoseForm = Film-coated tablet</a></li></ul><p><b>role</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000072050 100000072072}\">Active</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Concept</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://spor.azure-api.net/sms/api/v2/SubstanceDefinition 100000091531}\">Ethinylestradiol betadex clathrate</span></td></tr></table><blockquote><p><b>strength</b></p><p><b>presentation</b>: 173.17 microgram(s)<span style=\"background: LightGoldenRodYellow\"> (Details: Unit of Measurement EMA code100000110656 = 'microgram(s)')</span>/1 tablet<span style=\"background: LightGoldenRodYellow\"> (Details: Unit of Presentation EMA code200000002152 = 'Tablet')</span></p><blockquote><p><b>referenceStrength</b></p><h3>Substances</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Concept</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://spor.azure-api.net/sms/api/v2/SubstanceDefinition 100000091721}\">Ethinylestradiol</span></td></tr></table><p><b>strength</b>: 20 microgram(s)<span style=\"background: LightGoldenRodYellow\"> (Details: Unit of Measurement EMA code100000110656 = 'microgram(s)')</span>/1 tablet<span style=\"background: LightGoldenRodYellow\"> (Details: Unit of Presentation EMA code200000002152 = 'Tablet')</span></p></blockquote></blockquote></blockquote></div>"
},
"status" : "active",
"for" : [
{
🔗 "reference" : "MedicinalProductDefinition/Yaz-0023mg-tablet-SE-AJ-MPD"
},
{
🔗 "reference" : "ManufacturedItemDefinition/Yaz-0023mg-tablet-SE-AJ-MID01"
},
{
🔗 "reference" : "AdministrableProductDefinition/Yaz-0023mg-tablet-SE-AJ-APD01"
}
],
"role" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000072050",
"code" : "100000072072",
"display" : "Active"
}
]
},
"substance" : {
"code" : {
"concept" : {
"coding" : [
{
"system" : "https://spor.azure-api.net/sms/api/v2/SubstanceDefinition",
"code" : "100000091531",
"display" : "Ethinylestradiol betadex clathrate"
}
]
}
},
"strength" : [
{
"presentationRatio" : {
"numerator" : {
"value" : 173.17,
"unit" : "microgram(s)",
"system" : "https://spor.ema.europa.eu/v1/lists/100000110633",
"code" : "100000110656"
},
"denominator" : {
"value" : 1,
"unit" : "tablet",
"system" : "https://spor.ema.europa.eu/v1/lists/200000000014",
"code" : "200000002152"
}
},
"referenceStrength" : [
{
"substance" : {
"concept" : {
"coding" : [
{
"system" : "https://spor.azure-api.net/sms/api/v2/SubstanceDefinition",
"code" : "100000091721",
"display" : "Ethinylestradiol"
}
]
}
},
"strengthRatio" : {
"numerator" : {
"value" : 20,
"unit" : "microgram(s)",
"system" : "https://spor.ema.europa.eu/v1/lists/100000110633",
"code" : "100000110656"
},
"denominator" : {
"value" : 1,
"unit" : "tablet",
"system" : "https://spor.ema.europa.eu/v1/lists/200000000014",
"code" : "200000002152"
}
}
}
]
}
]
}
}
},
{
"fullUrl" : "https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/Ingredient/Yaz-0023mg-tablet-SE-AJ-ING03",
"resource" : {
"resourceType" : "Ingredient",
"id" : "Yaz-0023mg-tablet-SE-AJ-ING03",
"meta" : {
"profile" : [
🔗 "http://unicom-project.eu/fhir/StructureDefinition/PPLIngredient"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Ingredient_Yaz-0023mg-tablet-SE-AJ-ING03\"> </a><p class=\"res-header-id\"><b>Generated Narrative: Ingredient Yaz-0023mg-tablet-SE-AJ-ING03</b></p><a name=\"Yaz-0023mg-tablet-SE-AJ-ING03\"> </a><a name=\"hcYaz-0023mg-tablet-SE-AJ-ING03\"> </a><a name=\"hcYaz-0023mg-tablet-SE-AJ-ING03-en-US\"> </a><p><b>status</b>: Active</p><p><b>for</b>: </p><ul><li><a href=\"MedicinalProductDefinition-Yaz-0023mg-tablet-SE-AJ-MPD.html\">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100004813-00026267,http://ema.europa.eu/fhir/eurdId#10217; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Film-coated tablet; indication = Antikonception Vid beslut att förskriva Yasminelle 28 ska den enskilda kvinnans riskfaktorer beaktas, framför allt de för venös tromboembolism (VTE), och risken för VTE med Yasminelle 28 jämfört med andra kombinerade hormonella preventivmedel (se avsnitt 4.3 och 4.4).; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = drospirenone and ethinylestradiol</a></li><li><a href=\"ManufacturedItemDefinition-Yaz-0023mg-tablet-SE-AJ-MID01.html\">ManufacturedItemDefinition: status = active; manufacturedDoseForm = Film-coated tablet; unitOfPresentation = tablet</a></li><li><a href=\"AdministrableProductDefinition-Yaz-0023mg-tablet-SE-AJ-APD01.html\">AdministrableProductDefinition: status = active; administrableDoseForm = Film-coated tablet</a></li></ul><p><b>role</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000072050 100000072072}\">Active</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Concept</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://spor.azure-api.net/sms/api/v2/SubstanceDefinition 100000092375}\">drospirenone</span></td></tr></table><blockquote><p><b>strength</b></p><p><b>presentation</b>: 3 milligram(s)<span style=\"background: LightGoldenRodYellow\"> (Details: Unit of Measurement EMA code100000110655 = 'milligram(s)')</span>/1 tablet<span style=\"background: LightGoldenRodYellow\"> (Details: Unit of Presentation EMA code200000002152 = 'Tablet')</span></p><blockquote><p><b>referenceStrength</b></p><h3>Substances</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Concept</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://spor.azure-api.net/sms/api/v2/SubstanceDefinition 100000092375}\">drospirenone</span></td></tr></table><p><b>strength</b>: 3 milligram(s)<span style=\"background: LightGoldenRodYellow\"> (Details: Unit of Measurement EMA code100000110655 = 'milligram(s)')</span>/1 tablet<span style=\"background: LightGoldenRodYellow\"> (Details: Unit of Presentation EMA code200000002152 = 'Tablet')</span></p></blockquote></blockquote></blockquote></div>"
},
"status" : "active",
"for" : [
{
🔗 "reference" : "MedicinalProductDefinition/Yaz-0023mg-tablet-SE-AJ-MPD"
},
{
🔗 "reference" : "ManufacturedItemDefinition/Yaz-0023mg-tablet-SE-AJ-MID01"
},
{
🔗 "reference" : "AdministrableProductDefinition/Yaz-0023mg-tablet-SE-AJ-APD01"
}
],
"role" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000072050",
"code" : "100000072072",
"display" : "Active"
}
]
},
"substance" : {
"code" : {
"concept" : {
"coding" : [
{
"system" : "https://spor.azure-api.net/sms/api/v2/SubstanceDefinition",
"code" : "100000092375",
"display" : "drospirenone"
}
]
}
},
"strength" : [
{
"presentationRatio" : {
"numerator" : {
"value" : 3,
"unit" : "milligram(s)",
"system" : "https://spor.ema.europa.eu/v1/lists/100000110633",
"code" : "100000110655"
},
"denominator" : {
"value" : 1,
"unit" : "tablet",
"system" : "https://spor.ema.europa.eu/v1/lists/200000000014",
"code" : "200000002152"
}
},
"referenceStrength" : [
{
"substance" : {
"concept" : {
"coding" : [
{
"system" : "https://spor.azure-api.net/sms/api/v2/SubstanceDefinition",
"code" : "100000092375",
"display" : "drospirenone"
}
]
}
},
"strengthRatio" : {
"numerator" : {
"value" : 3,
"unit" : "milligram(s)",
"system" : "https://spor.ema.europa.eu/v1/lists/100000110633",
"code" : "100000110655"
},
"denominator" : {
"value" : 1,
"unit" : "tablet",
"system" : "https://spor.ema.europa.eu/v1/lists/200000000014",
"code" : "200000002152"
}
}
}
]
}
]
}
}
},
{
"fullUrl" : "https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/Organization/LOC-100016468",
"resource" : {
"resourceType" : "Organization",
"id" : "LOC-100016468",
"meta" : {
"profile" : [
🔗 "http://unicom-project.eu/fhir/StructureDefinition/PPLOrganization"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Organization_LOC-100016468\"> </a><p class=\"res-header-id\"><b>Generated Narrative: Organization LOC-100016468</b></p><a name=\"LOC-100016468\"> </a><a name=\"hcLOC-100016468\"> </a><a name=\"hcLOC-100016468-en-US\"> </a><p><b>identifier</b>: <code>https://spor.ema.europa.eu/v1/locations</code>/LOC-100016468</p><p><b>name</b>: Bayer AB</p></div>"
},
"identifier" : [
{
"system" : "https://spor.ema.europa.eu/v1/locations",
"value" : "LOC-100016468"
}
],
"name" : "Bayer AB"
}
}
]
}
IG © 2022+ UNICOM. Package hl7.eu.fhir.ufis-swe-unicom#0.1.0 based on FHIR 5.0.0. Generated 2024-06-28
Links: Table of Contents |
QA Report
The UNICOM Innovation Action has received funding from the European Union's Horizon 2020
research and innovation programme under grant agreement No. 875299.
